SEC Form 4 · accession 0001144204-15-036056
NEVRO CORP · NVRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Jun 8, 2015
Accepted (ET)
Jun 8, 2015 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 8, 2015 | S | 1,010,265 | $47.94 | D | 2,066,740 | I | By Johnson & Johnson Innovation - JJDC, Inc. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the public offering price of $51.00 per share, less the underwriter's discount of $3.06 per share.
- F2The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person (formerly known as Johnson & Johnson Development Corporation).